Lipid nanoparticles especially SLNs and NLCs are well trusted and long researched (almost 25 years) as a drug delivery platform in pharma for various biomedical applications. Literature has extensively discussed and recognized the role of excipient in formulation, stability, in vitro and in vivo effects of the lipid nanoparticles. Biocompatibility of lipid nanoparticles is highly dependent on nature and type of excipient used. The extensive use of wide ranged excipient in cosmetic and dermal application is reported, followed by average use in oral and pulmonary drug delivery. However, excipients administered via intravenous route are really limited and need to follow more strict guidelines on metal impurities, toxicity considerations beside their GRAS status.

German Innovation Award

Dr. Ranjita Shegokar, CSO was honored with a German Innovation Award 2022 jointly with Prof. Marc A. Reymond, MD MBA (AACSB), CEO, CapnoPharm GmbH, for their collaborative, innovative research work in the field of cancer.

ACES Award

German medical device firm races to provide alternative treatments to treat cancer

Revolutionizing Cancer Treatment


Hon’ble Ministers of State Shri Ashok Chandra Panda, Science & Technology, Public Enterprises, Social Security & Empowerment of Persons with Disability inaugurated the event in the auspicious presence of Padma Vibhusan Pandit Hariprasad Chaurasia and Padmashri Pt. Bhajan Sapori   15 women achievers in distinct categories felicitated with the prestigious award   Parichay Foundation presents… Continue reading AARYA Award

International Inspirational Women Awards 2020


16 Best New Drug Delivery Systems Books To Read In 2021 – BookAuthority